Premium
CLINICAL CHARACTERISTICS AND PROGNOSIS OF ELDERLY (>70 YEARS) FOLLICULAR LYMPHOMA IN THE RITUXIMAB ERA: MULTICENTRE RETROSPECTIVE ANALYSIS OF THE GELTAMO SPANISH GROUP
Author(s) -
Alcoceba M.,
Magnano L.,
AlonsoÁlvarez S.,
AndradeCampos M.,
EspinosaLara N.,
Rodríguez G.,
Sancho J.M.,
Moreno M.,
Mercadal S.,
GarcíaPallarols F.,
Cannata J.,
Teruel A.I.,
Rodríguez A.,
González de Villambrosía S.,
Bello J.,
López L.I.,
Monsalvo S.,
Novelli S.,
Cabo E.,
Infante M.S.,
Pardal E.,
Muntañola A.,
González M.,
Caballero M.D.,
Martín A.,
LópezGuillermo A.
Publication year - 2017
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.2439_122
Subject(s) - medicine , rituximab , follicular lymphoma , retrospective cohort study , fludarabine , lymphoma , comorbidity , gastroenterology , surgery , chemotherapy , cyclophosphamide
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom